The short answer is no, not through standard channels. Retatrutide is not TGA-approved for sale in Australia. You cannot walk into a pharmacy and buy it. But the full picture is more nuanced than that, and there are legal pathways worth knowing about.
Here is what the research shows, what the rules actually say, and what your real options are right now. legal pathways
What Is Retatrutide and What Does It Do?
Retatrutide is a triple hormone receptor agonist. It targets GLP-1, GIP, and glucagon receptors at the same time. That triple action is what makes it different from semaglutide or tirzepatide, which hit one or two of those receptors.
In a Phase 2 clinical trial published in The New England Journal of Medicine in 2023, participants taking the highest dose of retatrutide lost an average of 24.2% of their body weight over 48 weeks. That is more than any other drug in this class has shown in trials so far.
Eli Lilly is developing it. Phase 3 trials are underway. It is not approved anywhere in the world yet, including the United States, Europe, or Australia.
Is Retatrutide Approved for Sale in Australia?
No. The TGA has not approved retatrutide. It has no Australian Register of Therapeutic Goods entry. That means no doctor can prescribe it through normal channels and no pharmacy can dispense it.
What I found when looking into this is that a lot of people confuse retatrutide with tirzepatide or semaglutide, both of which do have TGA approval. Retatrutide is still in clinical development globally.
Can You Legally Purchase Retatrutide in Australia?
Not through retail or standard prescription routes. But there are two legal frameworks that could apply in specific circumstances.
1. The TGA Special Access Scheme
The Special Access Scheme, or SAS, lets registered medical practitioners apply to access unapproved therapeutic goods for individual patients. There are two categories that matter here.
SAS Category B requires the doctor to submit an application to the TGA before supplying the medicine. The TGA reviews it and either approves or rejects it. For a drug still in Phase 3 trials with no regulatory approval anywhere in the world, getting SAS-B approval is extremely difficult. The TGA needs evidence of safety and efficacy, and the manufacturer needs to be willing to supply it.
SAS Category A applies to patients who are seriously ill and where no other treatment is suitable. The doctor can supply without prior TGA approval but must notify the TGA within 28 days. This is reserved for life-threatening or seriously debilitating conditions.
In my experience looking at how these schemes work in practice, retatrutide access through SAS right now is close to impossible for most people. The drug is not commercially available even in countries where it is being trialled, and Eli Lilly is not supplying it outside of clinical trials.
2. Clinical Trial Participation
If you are in Australia and want access to retatrutide, the most realistic legal path is enrolling in a clinical trial. The Australian New Zealand Clinical Trials Registry lists active trials. Eli Lilly has been running Phase 3 trials internationally, and Australian sites have been involved in some GLP-1 class trials previously.
You can check clinicaltrials.gov or the ANZCTR to see if any retatrutide trials are recruiting in Australia. Eligibility criteria are strict, but this is the only way to access the drug legally and with medical supervision right now.
What About Buying Retatrutide Online?
This is where it gets important to be direct. There are websites selling what they label as retatrutide, often marketed as a research chemical or peptide. These are not pharmaceutical-grade products. They are not manufactured under TGA-regulated conditions. There is no quality control, no verified purity, and no dosing accuracy.
What I saw when researching this space is that many of these products are either mislabelled, underdosed, contaminated, or contain entirely different compounds. Importing unapproved therapeutic goods into Australia without TGA authorisation also carries legal risk under the Therapeutic Goods Act 1989.
The risk-to-benefit ratio here is not worth it. You do not know what you are injecting.
When Might Retatrutide Become Available in Australia?
Eli Lilly completed Phase 2 trials in 2023. Phase 3 trials are ongoing. If Phase 3 data is strong and Eli Lilly submits to the FDA and EMA, TGA approval in Australia could follow, but the TGA runs its own review process.
Realistically, if everything goes well, you are looking at 2026 at the earliest for potential TGA approval. That assumes Phase 3 data holds up, Eli Lilly submits a TGA application, and the review process moves at a standard pace. None of those are guaranteed.
For context, tirzepatide was approved by the FDA in 2022 for type 2 diabetes and in 2023 for weight management. TGA approval for weight management in Australia came in 2024. There is typically a lag.
Are There Alternatives to Retatrutide Available in Australia Right Now?
Yes, and some of them have strong clinical data behind them.
Semaglutide
Semaglutide is a GLP-1 receptor agonist. The injectable version, Ozempic, is TGA-approved for type 2 diabetes. Wegovy, the higher-dose version for weight management, received TGA approval in 2023. In the STEP 1 trial, participants lost an average of 14.9% of body weight over 68 weeks.
Tirzepatide
Tirzepatide targets both GLP-1 and GIP receptors. It is sold as Mounjaro for diabetes and Zepbound for weight management. TGA approved Mounjaro in Australia in 2022. In the SURMOUNT-1 trial, the highest dose produced average weight loss of 22.5% over 72 weeks. That is close to what retatrutide showed in Phase 2, and tirzepatide is available now.
In my experience, tirzepatide is the closest thing to retatrutide that Australians can actually access legally today. The dual receptor action and the weight loss data make it the most comparable option currently on the market.
Liraglutide
Liraglutide, sold as Saxenda, is TGA-approved for weight management. It is a daily injection. The weight loss outcomes are more modest than semaglutide or tirzepatide, averaging around 8% in trials, but it is an established option with a long safety record.
FAQ
Can you buy retatrutide in Australia without a prescription?
No. Retatrutide has no TGA approval and cannot be legally purchased or prescribed in Australia through any standard channel.
Is retatrutide the same as semaglutide?
No. Semaglutide targets only the GLP-1 receptor. Retatrutide targets GLP-1, GIP, and glucagon receptors simultaneously. They are different drugs with different mechanisms and different trial data.
Can a doctor in Australia prescribe retatrutide?
Not through normal prescription pathways. A doctor could theoretically apply through the TGA Special Access Scheme, but approval is unlikely given the drug has no regulatory approval anywhere in the world yet.
Is retatrutide better than tirzepatide?
Phase 2 data showed higher average weight loss with retatrutide than tirzepatide. But Phase 2 trials are smaller and shorter than Phase 3. We do not have the full picture yet. Tirzepatide has completed Phase 3 trials and has real-world data behind it. Retatrutide does not.
Where can I find retatrutide clinical trials in Australia?
Check the Australian New Zealand Clinical Trials Registry at anzctr.org.au and clinicaltrials.gov. Search for retatrutide or LY3437943, which is its trial identifier.
What happens if I import retatrutide from overseas?
Importing unapproved therapeutic goods into Australia without TGA authorisation breaches the Therapeutic Goods Act 1989. Border Force can seize the goods. There are also serious health risks from unregulated products.
What Should Australians Do Right Now?
If weight loss is the goal, the tools available in Australia today are genuinely effective. Tirzepatide and semaglutide both have strong Phase 3 data and TGA approval. They work. Waiting for retatrutide while avoiding proven options does not make sense.
Work with a doctor who understands metabolic health and the current evidence base. The GLP-1 class of medications has changed what is possible for weight management, and the approved options are already producing results that were not achievable five years ago.
If you want structured support around nutrition, training, and the lifestyle side of things alongside any medical treatment, that is where working with a qualified online personal trainer adds real value. Medication changes the hormonal environment. Coaching builds the habits and the training that make those changes stick long term.
Retatrutide may well become available in Australia in the next few years. When it does, it will go through the same TGA review process as every other drug. Until then, the question of can you buy retatrutide in Australia has a clear answer, and the smarter move is to work with what is actually available, proven, and legal right now.
